Literature DB >> 15466845

Jail management of arrestees/inmates enrolled in community methadone maintenance programs.

Kevin Fiscella1, Andrew Moore, Judith Engerman, Sean Meldrum.   

Abstract

Anecdotal evidence suggests that many jails fail to adequately detoxify arrestees/inmates who are enrolled in methadone programs, but there are few empirical data. The objective of this study was to assess how jails manage arrestees/inmates enrolled in methadone programs. A national survey of 500 jails in the United States was conducted. Surveys were mailed to the 200 largest jails in the country in addition to a random sample of 300 of the remaining jails (10% sample). Jails were specifically asked about management of opiate dependency among arrestees/inmates enrolled in methadone programs. Weighted logistic regression analyses were conducted to assess predictors of continuing methadone during incarceration and use of recommended detoxification protocols. Among the 245 (49%) jails that responded, only 1 in 4 (27%) reported they contacted the methadone programs regarding dose, and only 1 in 8 (12%) continued methadone during the incarceration. Very few (2%) jails used methadone or other opiates for detoxification. Most used clonidine. However, half (48%) of jails failed to use clonidine, methadone, or other opiates to detoxify inmates from methadone. Weighted logistic regression models showed that moderately large jails and those located in the South and Midwest were significantly more likely to continue methadone. Very large jails, those with an estimated prevalence of opiate dependence of 6%-10% among arrestees/inmates, and those located in the Northeast were significantly more likely to use recommended detoxification protocols. Very few jails provided continuous treatment to arrested persons on methadone, and half failed to detoxify arrestees/inmates using recommended protocols. These practices jeopardize the health and well-being of persons enrolled in methadone programs and underscore the need for uniform national policies within jails.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466845      PMCID: PMC3455924          DOI: 10.1093/jurban/jth147

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  18 in total

1.  Selected in-treatment outcomes of long-term methadone maintenance treatment patients in New York State.

Authors:  P W Appel; H Joseph; A Kott; W Nottingham; E Tasiny; E Habel
Journal:  Mt Sinai J Med       Date:  2001-01

2.  Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999.

Authors:  K H Seal; A H Kral; L Gee; L D Moore; R N Bluthenthal; J Lorvick; B R Edlin
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

Review 3.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

Authors:  A T McLellan; D C Lewis; C P O'Brien; H D Kleber
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

Review 4.  Benign neglect or neglected abuse: drug and alcohol withdrawal in U.S. jails.

Authors:  Kevin Fiscella; Naomi Pless; Sean Meldrum; Paul Fiscella
Journal:  J Law Med Ethics       Date:  2004       Impact factor: 1.718

5.  Detoxification of sick addicts in prison.

Authors:  V P Dole
Journal:  JAMA       Date:  1972-04-17       Impact factor: 56.272

6.  Predictors of discharges against medical advice from a short-term hospital detoxification unit.

Authors:  S H Armenian; M A Chutuape; M L Stitzer
Journal:  Drug Alcohol Depend       Date:  1999-08-02       Impact factor: 4.492

Review 7.  Alpha2-adrenergic agonists in opioid withdrawal.

Authors:  Linda R Gowing; Michael Farrell; Robert L Ali; Jason M White
Journal:  Addiction       Date:  2002-01       Impact factor: 6.526

8.  Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts.

Authors:  T R Kosten; B J Rounsaville; H D Kleber
Journal:  Am J Drug Alcohol Abuse       Date:  1985       Impact factor: 3.829

Review 9.  Buprenorphine for the management of opioid withdrawal.

Authors:  L Gowing; R Ali; J White
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 10.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Authors:  R P Mattick; J Kimber; C Breen; M Davoli
Journal:  Cochrane Database Syst Rev       Date:  2002
View more
  19 in total

Review 1.  HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response.

Authors:  Theodore M Hammett
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

2.  Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.

Authors:  Timothy W Kinlock; Michael S Gordon; Robert P Schwartz; Terrence T Fitzgerald
Journal:  J Offender Rehabil       Date:  2010-02

3.  Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.

Authors:  Jeannia J Fu; Nickolas D Zaller; Michael A Yokell; Alexander R Bazazi; Josiah D Rich
Journal:  J Subst Abuse Treat       Date:  2013-02-22

4.  Premature discharge from methadone treatment: patient perspectives.

Authors:  Heather Schacht Reisinger; Robert P Schwartz; Shannon Gwin Mitchell; James A Peterson; Sharon M Kelly; Kevin E O'Grady; Erica A Marrari; Barry S Brown; Michael H Agar
Journal:  J Psychoactive Drugs       Date:  2009-09

5.  Exploitation of Prisoners in Clinical Research: Perceptions of Study Participants.

Authors:  Paul P Christopher; Michael D Stein; Jennifer E Johnson; Josiah D Rich; Peter D Friedmann; Jennifer Clarke; Charles W Lidz
Journal:  IRB       Date:  2016 Jan-Feb

6.  Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.

Authors:  Josiah D Rich; Michelle McKenzie; Sarah Larney; John B Wong; Liem Tran; Jennifer Clarke; Amanda Noska; Manasa Reddy; Nickolas Zaller
Journal:  Lancet       Date:  2015-05-28       Impact factor: 79.321

7.  Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review.

Authors:  Kelly E Moore; Walter Roberts; Holly H Reid; Kathryn M Z Smith; Lindsay M S Oberleitner; Sherry A McKee
Journal:  J Subst Abuse Treat       Date:  2018-12-15

8.  Medication-Assisted Treatment and Violent Outcomes in Community-Based Offenders with Alcohol and Drug Use Problems.

Authors:  Sarah L Desmarais; Julie S Gray; Candalyn B Rade; Amy M Cohn; Stephen Doherty; Kevin Knight
Journal:  Psychol Violence       Date:  2016-03-24

9.  "I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.

Authors:  Jeronimo A Maradiaga; Shadi Nahvi; Chinazo O Cunningham; Jennifer Sanchez; Aaron D Fox
Journal:  J Subst Abuse Treat       Date:  2015-11-25

10.  Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users.

Authors:  Shannon Gwin Mitchell; Sharon M Kelly; Barry S Brown; Heather Schacht Reisinger; James A Peterson; Adrienne Ruhf; Michael H Agar; Robert P Schwartz
Journal:  J Psychoactive Drugs       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.